2023 |
Health Products (Active Ingredients) Regulations 2023
|
S 831/2023
|
|
2021 |
Health Products (Advertisement of Therapeutic Products) (Amendment) Regulations 2021
|
S 109/2021
|
|
2016 |
Health Products (Advertisement of Therapeutic Products) Regulations 2016
|
S 333/2016
|
|
2023 |
Health Products (Cell, Tissue and Gene Therapy Products) (Amendment No. 2) Regulations 2023
|
S 801/2023
|
|
2021 |
Health Products (Cell, Tissue and Gene Therapy Products) (Amendment) Regulations 2021
|
S 1076/2021
|
|
2022 |
Health Products (Cell, Tissue and Gene Therapy Products) (Amendment) Regulations 2022
|
S 451/2022
|
|
2023 |
Health Products (Cell, Tissue and Gene Therapy Products) (Amendment) Regulations 2023
|
S 437/2023
|
|
2021 |
Health Products (Cell, Tissue and Gene Therapy Products) Regulations 2021
|
S 104/2021
|
|
2021 |
Health Products (Clinical Research Materials) (Amendment No. 2) Regulations 2021
|
S 730/2021
|
|
2023 |
Health Products (Clinical Research Materials) (Amendment No. 2) Regulations 2023
|
S 802/2023
|
|
2021 |
Health Products (Clinical Research Materials) (Amendment No. 3) Regulations 2021
|
S 1078/2021
|
|
2022 |
Health Products (Clinical Research Materials) (Amendment) Regulations 2022
|
S 452/2022
|
|
2023 |
Health Products (Clinical Research Materials) (Amendment) Regulations 2023
|
S 430/2023
|
|
2021 |
Health Products (Clinical Trials) (Amendment No. 2) Regulations 2021
|
S 731/2021
|
|
2023 |
Health Products (Clinical Trials) (Amendment No. 2) Regulations 2023
|
S 803/2023
|
|
2021 |
Health Products (Clinical Trials) (Amendment No. 3) Regulations 2021
|
S 1077/2021
|
|
2021 |
Health Products (Clinical Trials) (Amendment) Regulations 2021
|
S 107/2021
|
|
2023 |
Health Products (Clinical Trials) (Amendment) Regulations 2023
|
S 431/2023
|
|
2016 |
Health Products (Clinical Trials) Regulations 2016
|
S 331/2016
|
|
2016 |
Health Products (Composition of Offences) (Amendment) Regulations 2016
|
S 540/2016
|
|